Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines

Margaret A. Tempero, Mokenge P. Malafa, E. Gabriela Chiorean, Brian Czito, Courtney Scaife, Amol K. Narang, Christos Fountzilas, Brian M. Wolpin, Mahmoud Al-Hawary, Horacio Asbun, Stephen W. Behrman, Al B. Benson, Ellen Binder, Dana B. Cardin, Charles Cha, Vincent Chung, Mary Dillhoff, Efrat Dotan, Cristina R. Ferrone, George FisherJeffrey Hardacre, William G. Hawkins, Andrew H. Ko, Noelle LoConte, Andrew M. Lowy, Cassadie Moravek, Eric K. Nakakura, Eileen M. O’Reilly, Jorge Obando, Sushanth Reddy, Sarah Thayer, Robert A. Wolff, Jennifer L. Burns, Griselda Zuccarino-Catania

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Abstract

The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

Original languageEnglish (US)
Pages (from-to)203-210
Number of pages8
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume17
Issue number3
DOIs
StatePublished - Mar 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this